Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization

RegulatoryapprovedPositive

AI Analysis

Summary

Porton Advanced Solutions Ltd. has been granted a Drug Manufacturing License (Class C) by China's NMPA, expanding its CDMO capabilities to commercialization services.

Outcome Details

Drug Manufacturing License (Class C) granted by NMPA

Importance:5/10

Sentiment:

0.70

CDMOManufacturingChinaRegulatory ApprovalClass C License

Related Companies

$NHC $MDCE $CHHE

Read the original article

Published by PR Newswire Pharma on August 5, 2026 11:31 AM

Read Original